A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

Alcon Research523 enrolled

Overview

The purpose of this study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

523

Conditions

Open-angle Glaucoma Ocular Hypertension

Interventions

Brinzolamide 10 mg/ml + Timolol 5 mg/ml eye drops, suspensionDRUG

One drop twice daily in each study eye for six months

Brinzolamide 10 mg/ml (AZOPT) eye drops, suspensionDRUG

One drop twice daily in each study eye for six months

Timolol 5 mg/ml eye drops, solutionDRUG

One drop twice daily in each study eye for six months

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 18 years of age or older * Diagnosis of open-angle glaucoma * Other protocol-defined inclusion criteria may apply Exclusion Criteria: * Under 18 * Pregnant * Other protocol-defined exclusion criteria may apply

Locations (1)

United States Investigative Sites

Fort Worth, Texas, United States

Outcomes

Primary Outcomes

Mean intra-ocular pressure (IOP)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.